1-12 of 12
Adriano Salaroli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Return to Work after Allogeneic HSCT: Further Insights in the Patients-Related Predictive Factors (The SOPRALLO Project)

Yana Stepanishyna, Sebastian Wittnebel, Fabio Andreozzi, Adriano Salaroli, Paulus Kristanto, Chloe Spilleboudt, Marie France Jaivenois, Sandra Michiels, Rezarta Ajazi, Charlotte Vandevoorde, Virginie De Wilde, Nathalie Meuleman, Philippe Lewalle, Dominique Bron, Sule Mine Bakanay Ozturk
Journal: Blood
Blood (2024) 144 (Supplement 1): 4929.
https://doi.org/10.1182/blood-2024-209736
Published: 2024
Journal Articles

Interim Results from the Phase I Deplethink Trial Evaluating the Infusion of a NKG2D CAR T-Cell Therapy Post a Non-Myeloablative Conditioning in Relapse or Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients

A. Samer Al-Homsi, MD, Enkhtsetseg Purev, MD PhD, Philippe Lewalle, Maher Abdul-Hay, MD, Daniel A Pollyea, MD, Adriano Salaroli, MD, Thomas Lequertier, Erik Alcantar-Orozco, MD, Fabian Borghese, Caroline Lonez, PhD, Nathalie Braun, Florence Renard, Anne Flament, MD, Ine Moors, MD, Tessa Kerre
Journal: Blood
Blood (2019) 134 (Supplement_1): 3844.
https://doi.org/10.1182/blood-2019-128267
Published: 2019
Journal Articles

Outcome of Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) and/or 17p Deletion/ TP 53 Mutations Treated with Ibrutinib According to a Named Patient Program (NPP) in Italy: Preliminary Analysis of a Real Life Retrospective Study

Francesca Romana Mauro, MD PhD, Alessandra Tedeschi, Alfonso Piciocchi, BS, Marina Motta, MD, Emilia Iannella, MD, Lucia Farina, MD PhD, Lydia Scarfo, Roberto Marasca, MD, Marta Coscia, MD PhD, Agostino Cortelezzi, MD, Luca Laurenti, Angela Melpignano, MD, Pier Luigi Zinzani, MD PhD, Stefano Molica, MD, Francesca Re, MD, Alessandro Andriani, MD, Donatella Iolanda Vincelli, MD, Carlo Visco, MD, Alessandro Gozzetti, MD, Ester Maria Orlandi, MD, Livio Trentin, MD, Monica Tani, Catello Califano, MD, Giuseppe Tagariello, MD, Paolo Ghia, MD PhD, Maria Denise Caputo, MD, Adriano Salaroli, MD, Idanna Innocenti, MD, Anna Frustaci, MD, Candida Vitale, MD, Marta Petullà, PharmD, Paolo de Fabritiis, MD, Marco Vignetti, MD, Paola Fazi, MD, Robin Foà
Journal: Blood
Blood (2016) 128 (22): 2038.
https://doi.org/10.1182/blood.V128.22.2038.2038
Published: 2016
Journal Articles

Role of CD133 As a Marker of Previous Myelodysplasia in De Novo Elderly Patients with Acute Myeloid Leukemia

Massimo Breccia, Maria Stefania De Propris, PhD, Mariella D'Angiò, MD, Caterina Stefanizzi, Sara Raponi, Roberto Latagliata, MD, Francesca Mancini, Anna Maria Testi, Saveria Capria, MD, Silvia Maria Trisolini, Clara Minotti, MD, Marta Chisini, Daniela Diverio, Teresa Ceglie, MD, Marco Mancini, Federico Vozella, Gioia Colafigli, Adriano Salaroli, Anna Guarini, PhD, Robin Foà
Journal: Blood
Blood (2014) 124 (21): 1063.
https://doi.org/10.1182/blood.V124.21.1063.1063
Published: 2014
Journal Articles

Acute Myeloid Leukemia Patients with an Undefined Genetic Profile at Diagnosis: Clinical and Prognostic Aspects

Marco Mancini, Teresa Ceglie, MD, Saveria Capria, MD, Anna Maria Testi, Roberto Latagliata, MD, Maria Stefania De Propris, PhD, Silvia Trisolini, Massimo Breccia, Clara Minotti, MD, Marta Chisini, Mariella D'Angiò, MD, Federico Vozella, Gioia Colafigli, Adriano Salaroli, Sara Raponi, Caterina Stefanizzi, Daniela Diverio, Francesca Mancini, Anna Guarini, PhD, Robin Foà
Journal: Blood
Blood (2014) 124 (21): 5326.
https://doi.org/10.1182/blood.V124.21.5326.5326
Published: 2014
Journal Articles

Independent Prognostic Impact of CD15 for Achievement of Complete Remission in Patients with Acute Myeloid Leukemia

Teresa Ceglie, MD, Marta Chisini, Federico Vozella, Gioia Colafigli, Caterina Stefanizzi, Adriano Salaroli, Mariella D'Angiò, MD, Marco Mancini, Daniela Diverio, Massimo Breccia, MD, Francesca Mancini, Sara Raponi, PhD, Clara Minotti, MD, Silvia Trisolini, Saveria Capria, MD, Anna Maria Testi, Anna Guarini, PhD, Roberto Latagliata, MD, Maria Stefania De Propris, PhD, Robin Foa, MD
Journal: Blood
Blood (2014) 124 (21): 3687.
https://doi.org/10.1182/blood.V124.21.3687.3687
Published: 2014
Journal Articles

Exclusion Criteria In The Dasision and Enestnd Trials: Which Could Their Impact Be On The Front-Line Treatment Of a “Real-life” Patient Population With Chronic Myelogenous Leukemia?

Roberto Latagliata, MD, Ida Carmosino, Federico Vozella, Paola Volpicelli, MD, Giuseppina Loglisci, Michelina Santopietro, Adriano Salaroli, MD, Angela Romano, Chiara Montagna, Amanda Roberto, Alessandra Serrao, Daniela Diverio, PhD, Mauro Nanni, PhD, Marco Mancini, Agostino Tafuri, Massimo Breccia, Giuliana Alimena, MD
Journal: Blood
Blood (2013) 122 (21): 4002.
https://doi.org/10.1182/blood.V122.21.4002.4002
Published: 2013
Journal Articles

Incidence of Late Chronic Anemia in Newly Diagnosed Patients with Chronic Myelogenous Leukemia Responsive to Imatinib

Paola Volpicelli, MD, Roberto Latagliata, MD, Massimo Breccia, Federico Vozella, Paola Finsinger, Ida Carmosino, Giuseppina Loglisci, MD, Michelina Santopietro, MD, Adriano Salaroli, Daniela Diverio, PhD, Marco Mancini, MD, Agostino Tafuri, Giuliana Alimena
Journal: Blood
Blood (2012) 120 (21): 3769.
https://doi.org/10.1182/blood.V120.21.3769.3769
Published: 2012
Journal Articles

Long-Term Follow-up of Chronic Phase Chronic Myeloid Leukemia Patients Who Failed Interferon Alpha and Switched to Imatinib

Massimo Breccia, Giuseppina Loglisci, MD, Adriano Salaroli, MD, Alessandra Serrao, MD, Irene Zacheo, MD, Roberto Latagliata, MD, Giuliana Alimena
Journal: Blood
Blood (2012) 120 (21): 3742.
https://doi.org/10.1182/blood.V120.21.3742.3742
Published: 2012
Journal Articles

Delayed Cytogenetic Response and Reduced Rate of Major Molecular Response Associated to Increased Body Mass Index At Baseline in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Imatinib.

Massimo Breccia, Giuseppina Loglisci, MD, Adriano Salaroli, MD, Alessandra Serrao, MD, Paola Volpicelli, MD, Daniela Diverio, PhD, Roberto Latagliata, MD, Giuliana Alimena
Journal: Blood
Blood (2012) 120 (21): 2784.
https://doi.org/10.1182/blood.V120.21.2784.2784
Published: 2012
Journal Articles

MDS-Specific Comorbidity Index (MDS-CI) Identifies Overall Survival Differences in Myelodysplastic Syndrome Patients,

Massimo Breccia, Vincenzo Federico, Giuseppina Loglisci, Roberto Latagliata, Michelina Santopietro, Adriano Salaroli, Alessandra Serrao, Gioia Colafigli, Agostino Tafuri, Giuliana Alimena
Journal: Blood
Blood (2011) 118 (21): 3793.
https://doi.org/10.1182/blood.V118.21.3793.3793
Published: 2011
Journal Articles

Myelodysplastic Syndrome Patients Younger Than 50 Years: Epidemiological Data and Clinical Features

Massimo Breccia, PhD, Paola Finsinger, Roberto Latagliata, MD, Laura Cannella, PhD, Giuseppina Loglisci, PhD, Mauro Nanni, PhD, Michelina Santopietro, PhD, Adriano Salaroli, PhD, Agostino Tafuri, Giuliana Alimena, PhD
Journal: Blood
Blood (2010) 116 (21): 4976.
https://doi.org/10.1182/blood.V116.21.4976.4976
Published: 2010